1 study found for:    ACNS1021
Show Display Options
Rank Status Study
1 Active, not recruiting Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Conditions: Childhood Cerebral Astrocytoma/Malignant Glioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Mixed Glioma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma
Interventions: Drug: sunitinib malate;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years